Oxygen Biotherapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 23   

Articles published

OXBT 4.19 -0.01 (-0.24%)
price chart
Oxygen Biotherapeutics to Present at Wedbush 2014 Life Sciences ...
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that John Kelley, Chief Executive Officer, will present a ...
Related articles »  
Hot News : Facebook Inc (NASDAQ:FB), Oxygen Biotherapeutics (NASDAQ ...
Morrisville drug developer Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) will grant $500,000 to Imperial College London to advance a study on a potential new drug that could benefit Oxygen in the future.
Oxygen Biotherapeutics To Present At Wedbush Conference; Webcast At 1:20 ...
(RTTNews.com) - Oxygen Biotherapeutics Inc. ( OXBT ) will present at the Wedbush 2014 Life Sciences Management Access Conference at Le Parker Meridien in New York.
Related articles »  
Momentum Stocks: Southwest Airlines Co. (NYSE:LUV), Oxygen Biotherapeutics ...
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, on 6 August announced a collaboration with Imperial College London to ...
Related articles »  
Hot Watch List: NanoString Technologies, Inc. (NASDAQ:NSTG), Oxygen ...
On 7 AUG Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) announced that John Kelley Chief Executive Officer will present a company overview at the Wedbush 2014 Life Sciences Management Access Conference at Le Parker Meridien in New York on ...
Oxygen Biotherapeutics Announces Collaboration with Imperial College London ...
MORRISVILLE, N.C., Aug 06, 2014 (BUSINESS WIRE) -- Oxygen Biotherapeutics, Inc. OXBT, +0.96% a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced a ...
Related articles »  
Stocks to Watch: Oxygen Biotherapeutics (NASDAQ:OXBT), Polycom (NASDAQ ...
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced that John Kelley, Chief Executive Officer, will present a company ...
Active Stocks : Guidance Software (NASDAQ:GUID), Oxygen Biotherapeutics ...
On AUG 6, Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced a collaboration with Imperial College London to provide ...
Related articles »  
Hot Watch List : Oxygen Biotherapeutics (NASDAQ:OXBT), Google Inc (NASDAQ ...
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced that John Kelley, Chief Executive Officer, will present a company ...
Related articles »  
Hot Alert : Coronado Biosciences (NASDAQ:CNDO), Repros Therapeutics Inc ...
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a pharmaceutical company specializing on critical care products, will partner with Imperial College London to supply additional funding in an ongoing Phase III trial investigating levosimendan in cardiac ...